Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Topical treatment may be as effective as electrocautery for anal neoplasia but with fewer adverse effects.
A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.
Treating abnormal anal cell changes early can reduce the risk of progression to anal cancer in people living with HIV.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
Women living with HIV in the United States have a greater likelihood of developing cervical cancer than HIV-negative women.
Study suggests HIV-positive women could start cervical cancer screening at age 21.
The early cancer is detected, the easier it is to treat.
Results from a study conducted in the Bronx, New York, serve as an important reminder to HIV care providers: Comprehensive screening for preca...
A new study from a Veterans Affairs (VA) HIV clinic in Miami found that instituting widespread anal cancer screening among its HIV-positive pa...
Despite being at greater risk for cervical cancer, nearly one in four HIV-positive women in the United States has not had a Pap smear to detec...
Testosterone for women: Low testosterone levels often cause irregular periods, fatigue, and weight and bone loss in women with HIV.
A leading HIV specialist and two HIV-positive men who’ve survived anal cancer argue that anal Paps are lifesavers.
Stephen Gendin goes in for a Pap smear and comes out with a date for surgery.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.